Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
THC — Tenet Healthcare Corporation
NYSE
FULL STOCK PAGE →

Tenet Healthcare (THC) Q1 2026 Earnings Call Summary

APR 30, 2026 2 MIN READ
REVENUE
$5.37B -2.9%
NET MARGIN
13.1% +6.4 PTS
EPS
$8.09 +90.4%
FREE CASH FLOW
$1.46B +298.1%

1Key Financial Results and Metrics

Net Operating Revenues: $5.4 billion

Consolidated Adjusted EBITDA: $1.16 billion, representing a margin of 21.6%

USPI Adjusted EBITDA: $484 million, with a margin of 36.7%

Hospital Segment Adjusted EBITDA: $678 million, with a margin of 16.7%

Same-Facility Revenue Growth (USPI): 5.3%

Adjusted Free Cash Flow: $978 million

Share Repurchases: 1.35 million shares for $318 million

Cash on Hand: $2.97 billion with no debt under the line of credit

2Strategic Updates and Business Highlights

USPI Performance: Strong start with significant growth in same-store volume for total joint replacements and a robust pipeline for acquisitions, investing $125 million to acquire 7 ASCs.

Hospital Segment: Focused on disciplined expense management and growth initiatives, maintaining margins despite headwinds from payer mix and exchange enrollment declines.

Technology Investments: Continued investments in AI and automation to improve operational efficiencies and clinical throughput.

Operational Resilience: Successfully managed impacts from winter storms and vendor cyber attacks, rescheduling procedures to mitigate disruptions.

3Forward Guidance and Outlook

Full Year 2026 Guidance: Reaffirmed with an expected adjusted EBITDA growth of 10% at the midpoint, excluding non-recurring items and impacts from the expiration of premium tax credits.

Q2 2026 Expectations: Anticipated consolidated adjusted EBITDA to be 24%-25% of the full year guidance.

Adjusted Free Cash Flow Projection: Expected to range between $1.6 billion to $1.83 billion, including $150 million in tax payments related to the Conifer transaction.

4Bad News, Challenges, or Points of Concern

Payer Mix Issues: Notable declines in exchange coverage, with same-store exchange admissions down 10% year-over-year, raising concerns about future volumes.

Uncompensated Care: Increase in uncompensated care linked to the expiration of exchange subsidies, though not significantly impacting overall hospital performance yet.

Operational Headwinds: Impact from weather-related disruptions and a decline in respiratory admissions, which traditionally contribute to higher volumes and margins.

Regulatory Risks: Ongoing uncertainty regarding Medicaid trends and potential impacts from upcoming outpatient rules from CMS.

5Notable Q&A Insights

Payer Denials: Management acknowledged high levels of payer disputes and denials, but noted no significant changes in trends compared to previous quarters.

Market Strategies: Discussion on successful strategies in various markets, emphasizing a focus on high-acuity service lines and operational efficiencies.

Length of Stay Management: Continued improvements in length of stay metrics despite a focus on higher acuity services, indicating effective capacity management.

Regulatory Outlook: Anticipation of regulatory changes, particularly regarding outpatient care reimbursement, with a focus on maintaining operational efficiency and value delivery. Overall, Tenet Healthcare reported a strong start to 2026 with solid financial performance, strategic investments, and a focus on operational efficiency, while also navigating challenges related to payer mix and regulatory uncertainties.

SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT